Jaco Botha

1.3k total citations
35 papers, 956 citations indexed

About

Jaco Botha is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Jaco Botha has authored 35 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Jaco Botha's work include Lysosomal Storage Disorders Research (11 papers), Blood Pressure and Hypertension Studies (8 papers) and Extracellular vesicles in disease (6 papers). Jaco Botha is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Blood Pressure and Hypertension Studies (8 papers) and Extracellular vesicles in disease (6 papers). Jaco Botha collaborates with scholars based in Switzerland, United States and United Kingdom. Jaco Botha's co-authors include Aase Handberg, Deborah Keefe, Aldo P. Maggioni, Campbell P. Howard, Gregg C. Fonarow, Eldrin F. Lewis, Mihai Gheorghiade, A Rissanen, Faı̈ez Zannad and Michael Böhm and has published in prestigious journals such as JAMA, Circulation and Hypertension.

In The Last Decade

Jaco Botha

31 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jaco Botha Switzerland	13	656	295	195	83	77	35	956
Lilián Grigorian-Shamagian Spain	16	545 0.8×	115 0.4×	140 0.7×	73 0.9×	95 1.2×	41	844
Frank P. Brouwers Netherlands	13	622 0.9×	104 0.4×	99 0.5×	67 0.8×	43 0.6×	20	866
Mio Nakazato Japan	15	284 0.4×	173 0.6×	74 0.4×	82 1.0×	136 1.8×	40	710
Jianlin Du China	17	320 0.5×	103 0.3×	184 0.9×	65 0.8×	53 0.7×	62	721
Biniyam G. Demissei United States	14	635 1.0×	87 0.3×	71 0.4×	162 2.0×	77 1.0×	34	869
Osamu Hirono Japan	18	782 1.2×	106 0.4×	106 0.5×	106 1.3×	140 1.8×	41	1.2k
George F. Wohlford United States	15	552 0.8×	105 0.4×	262 1.3×	73 0.9×	149 1.9×	32	923
Songbai Deng China	17	337 0.5×	106 0.4×	157 0.8×	52 0.6×	50 0.6×	44	702
Κ Katogiannis Greece	14	258 0.4×	141 0.5×	108 0.6×	45 0.5×	75 1.0×	59	619
Eralp Tutar Türkiye	12	462 0.7×	137 0.5×	126 0.6×	143 1.7×	96 1.2×	42	972

Countries citing papers authored by Jaco Botha

Since Specialization

Citations

This map shows the geographic impact of Jaco Botha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaco Botha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaco Botha more than expected).

Fields of papers citing papers by Jaco Botha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaco Botha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaco Botha. The network helps show where Jaco Botha may publish in the future.

Co-authorship network of co-authors of Jaco Botha

This figure shows the co-authorship network connecting the top 25 collaborators of Jaco Botha. A scholar is included among the top collaborators of Jaco Botha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaco Botha. Jaco Botha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zimran, Ari, Shoshana Revel‐Vilk, Tama Dinur, et al.. (2025). Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey. Orphanet Journal of Rare Diseases. 20(1). 43–43. 2 indexed citations

Zimran, Ari, Jaco Botha, Richard Eastell, et al.. (2025). Bone mineral density improvements in velaglucerase alfa-treated patients with Gaucher disease: Real-world data from the Gaucher Outcome Survey (GOS). Molecular Genetics and Metabolism. 144(2). 108991–108991.

Revel‐Vilk, Shoshana, Uma Ramaswami, Guillem Pintos‐Morell, et al.. (2025). Safety analysis of self-administered enzyme replacement therapy using data from the Fabry Outcome and Gaucher Outcome Surveys. Orphanet Journal of Rare Diseases. 20(1). 145–145.

Muenzer, Joseph, Hernán Amartino, Paul Harmatz, et al.. (2025). Unmet needs of adults living with mucopolysaccharidosis II: data from the Hunter Outcome Survey. Orphanet Journal of Rare Diseases. 20(1). 319–319. 1 indexed citations

Muenzer, Joseph, Hernán Amartino, Barbara K. Burton, et al.. (2024). Genotype–phenotype findings in patients with mucopolysaccharidosis II from the Hunter Outcome Survey. Molecular Genetics and Metabolism. 143(1-2). 108576–108576. 2 indexed citations

Elstein, Deborah, Nadia Belmatoug, Bruno Bembi, et al.. (2024). Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry. Journal of Clinical Medicine. 13(12). 3588–3588. 2 indexed citations

Hughes, Derralynn, Patrick Deegan, Pilar Giraldo, et al.. (2023). Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on “Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158”. Journal of Clinical Medicine. 12(12). 4017–4017. 1 indexed citations

Hughes, Derralynn, Patrick Deegan, Pilar Giraldo, et al.. (2022). Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). Journal of Clinical Medicine. 11(17). 5158–5158. 11 indexed citations

Botha, Jaco, Aase Handberg, & Jens B. Simonsen. (2022). Lipid‐based strategies used to identify extracellular vesicles in flow cytometry can be confounded by lipoproteins: Evaluations of annexin V, lactadherin, and detergent lysis. Journal of Extracellular Vesicles. 11(4). e12200–e12200. 31 indexed citations

10.

Botha, Jaco, et al.. (2018). Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin. Nutrition & Metabolism. 15(1). 76–76. 11 indexed citations

11.

Botha, Jaco, et al.. (2018). BLTR1 and CD36 Expressing Microvesicles in Atherosclerotic Patients and Healthy Individuals. Frontiers in Cardiovascular Medicine. 5. 156–156. 3 indexed citations

12.

Sprague, Stuart M., Adrian Covic, Jürgen Floege, et al.. (2016). Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients. American Journal of Nephrology. 44(2). 104–112. 15 indexed citations

13.

Gheorghiade, Mihai, Michael Böhm, Stephen J. Greene, et al.. (2013). Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure. JAMA. 309(11). 1125–1125. 238 indexed citations

14.

Rissanen, A, et al.. (2012). Effect of anti‐ IL ‐1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo‐controlled trial. Diabetes Obesity and Metabolism. 14(12). 1088–1096. 107 indexed citations

15.

Basile, Jan, et al.. (2011). Comparison of Aliskiren/Hydrochlorothiazide Combination Therapy With Hydrochlorothiazide Monotherapy in Older Patients With Stage 2 Systolic Hypertension: Results of the ACTION Study. Journal of Clinical Hypertension. 13(3). 162–169. 9 indexed citations

16.

Gheorghiade, Mihai, Mazen Albaghdadi, Faı̈ez Zannad, et al.. (2010). Rationale and Design of the Multicentre, Randomized, Double-Blind, Placebo-Controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT). European Journal of Heart Failure. 13(1). 100–106. 55 indexed citations

17.

Botha, Jaco, Leo Ihlberg, Abdelsalam M. Elhenawy, et al.. (2010). A Giant Cavernous Hemangioma of the Heart. The Annals of Thoracic Surgery. 90(1). 293–295. 16 indexed citations

18.

Palatini, Paolo, Won‐Sang Jung, Е. V. Shlyakhto, et al.. (2009). Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study. Journal of Human Hypertension. 24(2). 93–103. 56 indexed citations

19.

Duprez, Daniel, Mark Munger, Jaco Botha, Deborah Keefe, & Alan N. Charney. (2009). Aliskiren for Geriatric Lowering of Systolic Hypertension: a randomized controlled trial. Journal of Human Hypertension. 24(9). 600–608. 67 indexed citations

20.

Karalliedde, Janaka, Andrew H. Smith, Vincenzo Mirenda, et al.. (2008). Valsartan Improves Arterial Stiffness in Type 2 Diabetes Independently of Blood Pressure Lowering. Hypertension. 51(6). 1617–1623. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact